RxDoctor Payments Data

Jared Fields

Physician Assistant · London, KYNPI 1801179940

Payments from drug & device makers

$723in general payments, 2019–2025

Across 41 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$266
  • Lilly USA, LLC$115
  • Merck$87
  • AbbVie$72
  • GSK$32
  • Seqirus USA Inc$31
  • plus $120 from 6 others

What the payments were for

  • Food & beverage$723100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$723 in reported general payments places this provider in the 60th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$583
Medicare patients
24
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin93$75,092
OzempicSemaglutide66$65,629
RybelsusSemaglutide42$44,687
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$17,618
MounjaroTirzepatide16$17,058
LinzessLinaclotide18$13,854
FarxigaDapagliflozin Propanediol20$11,442
Breo ElliptaFluticasone/Vilanterol15$7,675
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$5,517
Novolog FlexpenInsulin Aspart14$2,256
Levothyroxine Sodium152$2,223
Atorvastatin Calcium296$1,486
Albuterol Sulfate HfaAlbuterol Sulfate51$1,308
Ventolin HfaAlbuterol Sulfate23$1,257
Ultra-Fine Nano Pen NeedlePen Needle, Diabetic19$1,054

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$266$110,316108 claims
GSKTrelegy Ellipta, Breo Ellipta$32$25,29342 claims
Lilly USA, LLCMounjaro$115$17,05816 claims
AbbVieLinzess, Synthroid$72$14,60837 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in London

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →